Prostate Cancer clinical trials

361 recruiting studies in the US for prostate cancer, cancer that develops in the prostate gland.

Prostate cancer trials are led by Phase 2 studies, including hormone therapy combinations, targeted radioligand treatments and imaging research. Eligibility often depends on PSA levels, whether cancer has spread, and whether it still responds to hormone therapy. Active-surveillance and survivorship studies are options for people with earlier-stage disease.